ReCerise Therapeutics Inc. ("ReCerise"), a company committed to research and development of first-in-class therapeutics in oncology, recently entered a research partnership with the National Cancer ...
ReCerise Therapeutics Inc. ("ReCerise"), a company committed to research and development of first-in-class therapeutics in oncology, recently entered a research partnership with the National Cancer ...
Hepatocellular carcinoma continues to pose a diagnostic challenge, particularly in the setting of underlying pathomorphological changes in the liver due to cirrhosis, steatosis, or steatohepatitis.
Researchers say if their results are confirmed through further study they are optimistic the approach could be used to treat chronic infections for the first time.
A robot upgrade is transforming cancer surgery in South Carolina. The Da Vinci SP made its way to the operating room for ...
A man living with advanced liver cancer has seen his tumour shrink by over half as “exciting” new clinical trials are ...
A mother of three who died days after receiving a liver cancer diagnosis is a tragically common case, a charity has said.
News Medical on MSN2d
Novel therapeutic approaches targeting the Wnt pathway in hepatocellular carcinomaHepatocellular carcinoma (HCC) is one of the deadliest cancers globally, with increasing incidence and mortality rates. It ...
A newly developed nomogram predicts preoperative microvascular invasion in patients with HCC, improving surgical planning and outcomes.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback